ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 275 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $600,369 | +81582.9% | 23,100 | -10.1% | 0.00% | -33.3% |
Q1 2024 | $735 | -15.7% | 25,700 | -9.8% | 0.00% | -25.0% |
Q4 2023 | $872 | +22.1% | 28,500 | +7.1% | 0.00% | +33.3% |
Q3 2023 | $714 | -24.7% | 26,600 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $948 | -52.5% | 26,600 | -66.2% | 0.00% | +33.3% |
Q1 2023 | $1,995 | +44.3% | 78,600 | +130.5% | 0.00% | -50.0% |
Q4 2022 | $1,383 | -99.9% | 34,100 | 0.0% | 0.01% | +20.0% |
Q3 2022 | $1,127,000 | -21.4% | 34,100 | -16.2% | 0.01% | -16.7% |
Q2 2022 | $1,433,000 | -21.1% | 40,700 | +3.0% | 0.01% | -14.3% |
Q1 2022 | $1,816,000 | -17.7% | 39,500 | +18.6% | 0.01% | -12.5% |
Q4 2021 | $2,207,000 | +12.9% | 33,300 | +6.4% | 0.01% | +14.3% |
Q3 2021 | $1,954,000 | -25.1% | 31,300 | -0.6% | 0.01% | -22.2% |
Q2 2021 | $2,608,000 | +46.3% | 31,500 | +17.1% | 0.01% | +28.6% |
Q1 2021 | $1,783,000 | -9.2% | 26,900 | +5.1% | 0.01% | -12.5% |
Q4 2020 | $1,964,000 | +104.6% | 25,600 | +14.8% | 0.01% | +100.0% |
Q3 2020 | $960,000 | -31.8% | 22,300 | -31.6% | 0.00% | -33.3% |
Q2 2020 | $1,407,000 | +31.5% | 32,600 | -12.4% | 0.01% | 0.0% |
Q1 2020 | $1,070,000 | -48.1% | 37,200 | +14.5% | 0.01% | -33.3% |
Q4 2019 | $2,061,000 | -14.1% | 32,500 | -61.9% | 0.01% | +80.0% |
Q3 2019 | $2,400,000 | +243.3% | 85,200 | +222.7% | 0.01% | +66.7% |
Q2 2019 | $699,000 | +202.6% | 26,400 | +109.5% | 0.00% | +200.0% |
Q1 2019 | $231,000 | – | 12,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |